AC
CELG

Addenda Capital’s Celgene Corp CELG Stock Holding History

Addenda Capital’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-27,458
Closed -$2.59M – 118
2019
Q1 		$2.59M Sell
27,458
-13,735
-33% -$1.2M 0.19% 78
2018
Q4 		$2.64M Buy
41,193
+952
+2% +$70.3K 0.23% 75
2018
Q3 		$3.6M Sell
40,241
-11,125
-22% -$983K 0.3% 58
2018
Q2 		$4.08M Sell
51,366
-4,798
-9% -$398K 0.33% 59
2018
Q1 		$5.01M Sell
56,164
-1,679
-3% -$161K 0.38% 61
2017
Q4 		$6.04M Buy
57,843
+2,626
+5% +$296K 0.42% 53
2017
Q3 		$8.05M Buy
55,217
+10,238
+23% +$1.39M 0.56% 41
2017
Q2 		$5.84M Sell
44,979
-1,859
-4% -$228K 0.44% 56
2017
Q1 		$5.83M Buy
46,838
+5,580
+14% +$668K 0.45% 55
2016
Q4 		$4.78M Buy
41,258
+18,052
+78% +$2.01M 0.38% 64
2016
Q3 		$2.29M Hold
23,206
– – 0.19% 94
2016
Q2 		$2.29M Buy
23,206
+9,341
+67% +$966K 0.19% 94
2016
Q1 		$1.39M Buy
+13,865
New +$1.43M 0.12% 102

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Addenda Capital's CELG Position: Q2 2019 in Review

Addenda Capital sold out of Celgene Corp (CELG) in Q2 2019, closing a stake of 27,458 shares — an estimated $2.59M sold.

Addenda Capital first reported a position in CELG in Q1 2016 and held it in 13 quarters. The position peaked at $8.05M in Q3 2017. 1,287 funds tracked by Wall St. Rank hold CELG as of Q2 2019.

  • Addenda Capital reported no remaining Celgene Corp position as of Q2 2019 after selling out during the quarter.
  • Addenda Capital sold 27,458 Celgene Corp shares in Q2 2019, an estimated $2.59M.
  • Addenda Capital first reported a position in Celgene Corp in Q1 2016 and held it in 13 quarters.
  • Addenda Capital's Celgene Corp position peaked at $8.05M in Q3 2017.
  • 1,287 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2019.

Based on Addenda Capital's 13F filing for Q2 2019, filed 12 Jul 2019.